Anti Viral

Efabiovir®

Brand Name:

Efabiovir®®

Generic Name:

Efavirenz

Pharmacotherapeutic Group:

Antiviral(systemic)

Therapeutic Indication:

Efabiovir in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.

Dosage and Administration:

The recommended dosage of Efabiovir is 600 mg, once daily, in combination with a protease inhibitor and/or nucleoside analogue reverse transcriptase inhibitors (NRTIs).

Side Effects:

COMMON :

  • Dermatologic: Pruritus, Rash 
  • Endocrine metabolic: Serum triglycerides raised, grades 3 to 4
  • Gastrointestinal: Diarrhea, Nausea
  • Hepatic: ALT (SGPT) level raised, grades 3 to 4, AST/SGOT level raised, grades 3 to 4, Gamma-glutamyl transferase raised, grades 3 to 4
  • Neurologic: Dizziness, Headache, Insomnia
  • Psychiatric: Depression, Unable to concentrate
  • Other: Fever

SERIOUS :

  • Dermatologic: Rash, grade 4
  • Psychiatric: At risk for suicide, Depression (Severe), Psychotic disorder, Suicidal thoughts

Copyright © 2019 Bakhtar Bioshimi Co, All rights reserved.